BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $3.67 | Prev. Close $3.50 | Circuit Range N/A |
Day Range $3.66 - $3.90 | Year Range $0.61 - $13.78 | Volume 4,982 |
Average Traded $3.79 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $3.67 | $3.85 | +0.00% |
20-May-26 | $3.67 | $3.85 | +14.58% |
18-May-26 | $3.20 | $3.36 | +10.89% |
15-May-26 | $4.01 | $3.03 | -24.81% |
14-May-26 | $4.05 | $4.03 | -3.59% |
13-May-26 | $4.07 | $4.18 | +2.83% |
12-May-26 | $4.07 | $4.07 | -1.57% |
FAQs on BriaCell Therapeutics Corp. Share Price
Can I buy BriaCell Therapeutics Corp. shares in India?
What is the share price of BriaCell Therapeutics Corp.?
What is the 5 year returns of BriaCell Therapeutics Corp.?
What are the high & low stock price of BriaCell Therapeutics Corp. today?
What is the 52-week high and low of BriaCell Therapeutics Corp. stock?